April 30, 2026
3:00 PM – 4:00 PM
On Thursday, April 30, 2026, Nusano’s senior director of research and development, Elvin Harms, will present an overview of the Nusano radioisotope production platform at Argonne National Laboratory.
Abstract:
Nusano, Inc. based in Salt Lake City is a privately held physics company committed to bringing supply stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market, and to serving industrial and commercial markets dependent on reliable access to high quality radioisotopes for their products and services. Driven by the company’s proprietary ion source, the Nusano production platform will generate radioisotopes in volumes and varieties exceeding other production methods. Nusano’s breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries.
In this seminar the speaker will provide an introduction to the Nusano linear accelerator and beam distribution platform – its unique features, current status, timeline to production, and future prospects.
For more information visit the Argonne National Laboratory website.
